Search Results
Found 14 results for browse/category/us/en/90217060.
RACE Act: A Promising Catalyst for Improved Pediatric Cancer Treatments
Developing targeted therapies for children in oncology has taken on a significantly higher priority now that the RACE ACT is in effect.
Prepare Now for EU Clinical Trial Regulation Go-Live Date
PPD’s cross-functional EU clinical trial regulation (CTR) readiness team continues to keep a close eye on the new EU CTR and its potential impacts, working to embrace this change and to ensure sponsors are ready from day one.
Cell and Gene Therapy
Working with a cell and gene therapy CRO across the development lifecycle fosters better integration of services and capabilities throughout your ATMP clinical trials.
Thermo Fisher Scientific’s PPD clinical research business wins clinical research company of the year title, receives multiple honors at PharmaTimes competition
WILMINGTON, N.C. (June 16, 2025) – The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving…
Thermo Fisher Scientific Earns Clinical Research Company of the Year Recognition, Honored with argenx at PharmaTimes Americas Competition
WILMINGTON, N.C., (November 12, 2025) – The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, has…